Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.1385
Delayed Data
As of May 03
 +0.0032 / +2.37%
Today’s Change
0.06
Today|||52-Week Range
0.29
+72.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues36.0K47.0K23.0K27.0K
 
 
 
 
 
Cost of Goods Sold121.0K221.0K61.0K5.0K
 
 
 
 
 
Depreciation And Amortization251.0K286.0K292.0K361.0K
 
 
 
 
 
 
Operating ExpensesGross Income-336.0K-460.0K-330.0K-339.0K
 
 
 
 
 
General Expenses4.6M4.4M3.7M2.5M
 
 
 
 
 
Research And Development2.7M2.4M2.0M957.0K
 
 
 
 
 
Total Operating Expenses5.0M4.9M4.0M2.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.9M-4.9M-4.0M-2.8M
 
 
 
 
 
Interest Expense On Debt2.0K0.001.0K0.00
 
 
 
Other Expenses1.4M0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.4M-4.8M-3.8M-3.1M
 
 
 
 
 
Net Income-3.4M-4.8M-3.8M-3.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS213.6M236.1M246.8M247.6M
 
 
 
 
 
Shares To Calculate EPS Diluted213.6M236.1M246.8M247.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.02-$0.02-$0.01
 
 
 
 
 
EPS Diluted-$0.02-$0.02-$0.02-$0.01